SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 211 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,391 | -51.0% | 54,004 | +6.1% | 0.00% | – |
| Q2 2023 | $66,156 | -3.9% | 50,889 | +30.1% | 0.00% | – |
| Q1 2023 | $68,825 | -37.1% | 39,105 | +12.3% | 0.00% | – |
| Q4 2022 | $109,378 | -26.6% | 34,834 | +15.0% | 0.00% | – |
| Q3 2022 | $149,000 | +53.6% | 30,290 | +30.0% | 0.00% | – |
| Q2 2022 | $97,000 | -54.9% | 23,292 | -37.0% | 0.00% | – |
| Q1 2022 | $215,000 | -21.2% | 36,982 | +1.3% | 0.00% | – |
| Q4 2021 | $273,000 | -41.5% | 36,524 | -29.6% | 0.00% | – |
| Q3 2021 | $467,000 | -23.9% | 51,871 | +1.1% | 0.00% | – |
| Q2 2021 | $614,000 | -12.3% | 51,320 | -8.2% | 0.00% | – |
| Q1 2021 | $700,000 | -23.0% | 55,885 | -4.1% | 0.00% | -100.0% |
| Q4 2020 | $909,000 | +134.9% | 58,271 | +42.2% | 0.00% | – |
| Q3 2020 | $387,000 | -1.3% | 40,966 | -6.4% | 0.00% | – |
| Q2 2020 | $392,000 | +92.2% | 43,773 | +36.9% | 0.00% | – |
| Q1 2020 | $204,000 | -20.3% | 31,966 | +4.5% | 0.00% | – |
| Q4 2019 | $256,000 | -10.5% | 30,595 | -3.3% | 0.00% | – |
| Q3 2019 | $286,000 | -5.9% | 31,651 | +12.3% | 0.00% | – |
| Q2 2019 | $304,000 | +8.2% | 28,192 | -4.1% | 0.00% | – |
| Q1 2019 | $281,000 | -12.7% | 29,405 | +4.6% | 0.00% | – |
| Q4 2018 | $322,000 | -77.1% | 28,102 | -66.1% | 0.00% | -100.0% |
| Q3 2018 | $1,407,000 | +28.0% | 83,019 | +7.3% | 0.00% | 0.0% |
| Q2 2018 | $1,099,000 | +6.2% | 77,399 | +42.1% | 0.00% | 0.0% |
| Q1 2018 | $1,035,000 | +24.8% | 54,480 | +7.7% | 0.00% | 0.0% |
| Q4 2017 | $829,000 | +399.4% | 50,570 | +356.7% | 0.00% | – |
| Q3 2017 | $166,000 | +45.6% | 11,074 | -14.7% | 0.00% | – |
| Q2 2017 | $114,000 | +81.0% | 12,978 | +6.8% | 0.00% | – |
| Q1 2017 | $63,000 | +70.3% | 12,146 | 0.0% | 0.00% | – |
| Q4 2016 | $37,000 | -33.9% | 12,146 | 0.0% | 0.00% | – |
| Q3 2016 | $56,000 | -20.0% | 12,146 | 0.0% | 0.00% | – |
| Q2 2016 | $70,000 | -4.1% | 12,146 | 0.0% | 0.00% | – |
| Q1 2016 | $73,000 | -31.8% | 12,146 | +3.2% | 0.00% | – |
| Q4 2015 | $107,000 | +62.1% | 11,773 | 0.0% | 0.00% | – |
| Q3 2015 | $66,000 | -50.4% | 11,773 | -1.6% | 0.00% | – |
| Q2 2015 | $133,000 | -22.7% | 11,968 | +9.2% | 0.00% | – |
| Q1 2015 | $172,000 | +3.0% | 10,957 | -0.1% | 0.00% | – |
| Q4 2014 | $167,000 | +10.6% | 10,973 | -21.7% | 0.00% | – |
| Q3 2014 | $151,000 | -29.4% | 14,010 | 0.0% | 0.00% | – |
| Q2 2014 | $214,000 | -37.8% | 14,010 | -26.4% | 0.00% | -100.0% |
| Q1 2014 | $344,000 | +45.1% | 19,033 | +11.4% | 0.00% | – |
| Q4 2013 | $237,000 | -16.3% | 17,082 | -36.7% | 0.00% | -100.0% |
| Q3 2013 | $283,000 | +25.8% | 27,003 | -6.1% | 0.00% | – |
| Q2 2013 | $225,000 | – | 28,772 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
| NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
| Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
| WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
| Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
| Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
| Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
| Leisure Capital Management | 43,008 | $131,000 | 0.12% |
| Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |